Salud financiera de hoja de balance de Ourpalm
Salud financiera controles de criterios 5/6
Ourpalm has a total shareholder equity of CN¥4.9B and total debt of CN¥10.1M, which brings its debt-to-equity ratio to 0.2%. Its total assets and total liabilities are CN¥5.3B and CN¥443.1M respectively. Ourpalm's EBIT is CN¥56.2M making its interest coverage ratio -0.5. It has cash and short-term investments of CN¥2.5B.
Información clave
0.2%
Ratio deuda-patrimonio
CN¥10.12m
Deuda
Ratio de cobertura de intereses | -0.5x |
Efectivo | CN¥2.53b |
Patrimonio | CN¥4.89b |
Total pasivo | CN¥443.06m |
Activos totales | CN¥5.33b |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Recent updates
Optimistic Investors Push Ourpalm Co., Ltd. (SZSE:300315) Shares Up 34% But Growth Is Lacking
Oct 04Is Now An Opportune Moment To Examine Ourpalm Co., Ltd. (SZSE:300315)?
Sep 18Ourpalm Co., Ltd.'s (SZSE:300315) Earnings Haven't Escaped The Attention Of Investors
Aug 19Ourpalm (SZSE:300315) Will Be Hoping To Turn Its Returns On Capital Around
Jun 19Is Now The Time To Look At Buying Ourpalm Co., Ltd. (SZSE:300315)?
May 24We Think Ourpalm's (SZSE:300315) Healthy Earnings Might Be Conservative
May 02Ourpalm Co., Ltd.'s (SZSE:300315) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Apr 17Subdued Growth No Barrier To Ourpalm Co., Ltd. (SZSE:300315) With Shares Advancing 27%
Mar 03Análisis de la situación financiera
Pasivos a corto plazo: 300315's short term assets (CN¥2.7B) exceed its short term liabilities (CN¥399.5M).
Pasivo a largo plazo: 300315's short term assets (CN¥2.7B) exceed its long term liabilities (CN¥43.6M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: 300315 has more cash than its total debt.
Reducción de la deuda: 300315's debt to equity ratio has increased from 0% to 0.2% over the past 5 years.
Cobertura de la deuda: 300315's debt is well covered by operating cash flow (509.5%).
Cobertura de intereses: 300315 earns more interest than it pays, so coverage of interest payments is not a concern.